Table 4 Additional tests and costs with HC2 and Cobas versus Aptima over 2 years of follow-up
From: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
Diagnostic tests* after the first HPV test, n = | Costs, € | Additional tests* versus Aptima, n = | Additional costs versus Aptima, € | |
|---|---|---|---|---|
Aptima® HPV | 1,137,309 | 11,794,860 € | – | – |
Hybrid Capture® 2 | 1,399,753 | 393,354,356.91 €** | 262,443 | 381,559,496.91 € |
Cobas® 4800 | 1,407,165 | 14,592,550.70 € | 269,856 | 2,797,690.71 € |